4.6 Review

Improving the Detection of Individuals at Clinical Risk for Psychosis in the Community, Primary and Secondary Care: An Integrated Evidence-Based Approach

期刊

FRONTIERS IN PSYCHIATRY
卷 10, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fpsyt.2019.00774

关键词

Clinical high risk; detection; e-health; prevention; psychosis; risk; schizophrenia

资金

  1. Boehringer Ingelheim International GmbH

向作者/读者索取更多资源

Background: The first rate-limiting step for improving outcomes of psychosis through preventive interventions in people at clinical high risk for psychosis (CHR-P) is the ability to accurately detect individuals who are at risk for the development of this disorder. Currently, this detection power is sub-optimal. Methods: This is a conceptual and nonsystematic review of the literature, focusing on the work conducted by leading research teams in the field. The results will be structured in the following sections: understanding the CHR-P assessment, validity of the CHR-P as a universal risk state for psychosis, and improving the detection of at-risk individuals in secondary mental health care, in primary care, and in the community. Results: CHR-P instruments can provide adequate prognostic accuracy for the prediction of psychosis provided that they are employed in samples who have undergone risk enrichment during recruitment. This substantially limits their detection power in real-world settings. Furthermore, there is initial evidence that not all cases of psychosis onset are preceded by a CHR-P stage. A transdiagnostic individualized risk calculator could be used to automatically screen secondary mental health care medical notes to detect those at risk of psychosis and refer them to standard CHR-P assessment. Similar risk estimation tools for use in primary care are under development and promise to boost the detection of patients at risk in this setting. To improve the detection of young people who may be at risk of psychosis in the community, it is necessary to adopt digital and/or sequential screening approaches. These solutions are based on recent scientific evidence and have potential for implementation internationally. Conclusions: The best strategy to improve the detection of patients at risk for psychosis is to implement a clinical research program that integrates different but complementary detection approaches across community, primary, and secondary care. These solutions are based on recent scientific advancements in the development of risk estimation tools and e-health approaches and have the potential to be applied across different clinical settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Psychology, Clinical

Impact of data extraction errors in meta-analyses on the association between depression and peripheral inflammatory biomarkers: an umbrella review

San Lee, Keum Hwa Lee, Kyung Mee Park, Sung Jong Park, Won Jae Kim, Jinhee Lee, Andreas Kronbichler, Lee Smith, Marco Solmi, Brendon Stubbs, Ai Koyanagi, Louis Jacob, Andrew Stickley, Trevor Thompson, Elena Dragioti, Hans Oh, Andre R. Brunoni, Andre F. Carvalho, Joaquim Radua, Suk Kyoon An, Kee Namkoong, Eun Lee, Jae Il Shin, Paolo Fusar-Poli

Summary: Errors in data extraction may account for discrepancies in previous meta-analyses on the association between depression and inflammatory biomarkers.

PSYCHOLOGICAL MEDICINE (2023)

Review Psychology, Developmental

Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response

Gonzalo Salazar de Pablo, Carolina Pastor Jorda, Julio Vaquerizo-Serrano, Carmen Moreno, Anna Cabras, Celso Arango, Patricia Hernandez, Jeremy Veenstra-VanderWeele, Emily Simonoff, Paolo Fusar-Poli, Paramala Santosh, Samuele Cortese, Mara Parellada

Summary: This meta-analysis found that antipsychotics and medications used to treat ADHD were significantly better than placebo in improving emotional dysregulation and irritability in individuals with ASD. Specifically, risperidone and aripiprazole showed efficacy in short-term treatment. However, other drug classes did not show evidence of efficacy. Lower efficacy was associated with comorbid epilepsy.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2023)

Article Psychology, Clinical

Psychosis and substance abuse increase the COVID-19 mortality risk

Ana Catalan, Claudia Aymerich, Amaia Bilbao, Borja Pedruzo, Jose Luis Perez, Nerea Aranguren, Gonzalo Salazar de Pablo, Emily Hedges, Patxi Gil, Rafael Segarra, Ana Gonzalez-Pinto, Aranzazu Fernandez-Rivas, Lucia Inchausti, Philip McGuire, Paolo Fusar-Poli, Miguel Angel Gonzalez-Torres

Summary: COVID-19-related mortality and hospitalization rates were higher for patients with pre-existing psychotic disorders, while patients with affective disorders had lower rates.

PSYCHOLOGICAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence

Marco Solmi, Giovanni Croatto, Giada Piva, Stella Rosson, Paolo Fusar-Poli, Jose M. Rubio, Andre F. Carvalho, Eduard Vieta, Celso Arango, Nicole R. DeTore, Elizabeth S. Eberlin, Kim T. Mueser, Christoph U. Correll

Summary: Psychosocial interventions play an important role in schizophrenia and early psychosis. However, the literature on this topic is heterogeneous and contradictory. This umbrella review summarizes the findings from multiple meta-analyses comparing the effectiveness of different psychosocial interventions with standard treatment or other active interventions. The results suggest that early intervention services and cognitive behavioral therapy have significant effects on symptom reduction and functional improvement in early psychosis. For schizophrenia patients, cognitive behavioral therapy, psychoeducation, and any family interventions show positive effects on symptom reduction, relapse prevention, and functional improvement.

MOLECULAR PSYCHIATRY (2023)

Editorial Material Neurosciences

Natural Language Processing: Unlocking the Potential of Electronic Health Record Data to Support Transdiagnostic Psychiatric Research

Rashmi Patel, Matthew Wickersham, Rudolf N. Cardinal, Paolo Fusar-Poli, Christoph U. Correll

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2023)

Article Developmental Biology

Progressive Voxel-Wise Homotopic Connectivity from childhood to adulthood: Age-related functional asymmetry in resting-state functional magnetic resonance imaging

Livio Tarchi, Stefano Damiani, Paolo La Torraca Vittori, Andreas Frick, Giovanni Castellini, Pierluigi Politi, Paolo Fusar-Poli, Valdo Ricca

Summary: Homotopic connectivity during resting state is considered a risk marker for neurologic and psychiatric conditions. This study examined voxel-mirrored homotopic connectivity (VMHC) in a sample of individuals aged 7-50 years, finding that VMHC decreased with age in minors but not in adults. Four functional networks showed negative correlations between VMHC and age in minors, suggesting that interhemispheric interactions shape late neurodevelopment.

DEVELOPMENTAL PSYCHOBIOLOGY (2023)

Article Clinical Neurology

Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

Marco Solmi, Trevor Thompson, Andres Estrade, Agorastos Agorastos, Joaquim Radua, Samuele Cortese, Elena Dragioti, Friedrich Leisch, Davy Vancampfort, Lau Caspar Thygesen, Harald Aschauer, Monika Schloegelhofer, Elena Aschauer, Andres Schneeberger, Christian G. Huber, Gregor Hasler, Philippe Conus, Kim Q. Do Cuenod, Roland von Kaenel, Gonzalo Arrondo, Paolo Fusar-Poli, Philip Gorwood, Pierre-Michel Llorca, Marie-Odile Krebs, Elisabetta Scanferla, Taishiro Kishimoto, Golam Rabbani, Karolina Skonieczna-Zydecka, Paolo Brambilla, Angela Favaro, Akihiro Takamiya, Leonardo Zoccante, Marco Colizzi, Julie Bourgin, Karol Kaminski, Maryam Moghadasin, Soraya Seedat, Evan Matthews, John Wells, Emilia Vassilopoulou, Ary Gadelha, Kuan-Pin Su, Jun Soo Kwon, Minah Kim, Tae Young Lee, Oleg Papsuev, Denisa Mankova, Andrea Boscutti, Cristiano Gerunda, Diego Saccon, Elena Righi, Francesco Monaco, Giovanni Croatto, Guido Cereda, Jacopo Demurtas, Natascia Brondino, Nicola Veronese, Paolo Enrico, Pierluigi Politi, Valentina Ciappolino, Andrea Pfennig, Andreas Bechdolf, Andreas Meyer-Lindenberg, Kai G. Kahl, Katharina Domschke, Michael Bauer, Nikolaos Koutsouleris, Sibylle Winter, Stefan Borgwardt, Istvan Bitter, Judit Balazs, Pal Czobor, Zsolt Unoka, Dimitris Mavridis, Konstantinos Tsamakis, Vasilios P. Bozikas, Chavit Tunvirachaisakul, Michael Maes, Teerayuth Rungnirundorn, Thitiporn Supasitthumrong, Ariful Haque, Andre R. Brunoni, Carlos Gustavo Costardi, Felipe Barreto Schuch, Guilherme Polanczyk, Jhoanne Merlyn Luiz, Lais Fonseca, Luana V. Aparicio, Samira S. Valvassori, Merete Nordentoft, Per Vendsborg, Sofie Have Hoffmann, Jihed Sehli, Norman Sartorius, Sabina Heuss, Daniel Guinart, Jane Hamilton, John Kane, Jose Rubio, Michael Sand, Ai Koyanagi, Aleix Solanes, Alvaro Andreu-Bernabeu, Antonia San Jose Caceres, Celso Arango, Covadonga M. Diaz-Caneja, Diego Hidalgo-Mazzei, Eduard Vieta, Javier Gonzalez-Penas, Lydia Fortea, Mara Parellada, Miquel A. Fullana, Norma Verdolini, Eva Andrlikova, Karolina Janku, Mark John Millan, Mihaela Honciuc, Anna Moniuszko-Malinowska, Igor Loniewski, Jerzy Samochowiec, Lukasz Kiszkiel, Maria Marlicz, Pawel Sowa, Wojciech Marlicz, Georgina Spies, Brendon Stubbs, Joseph Firth, Sarah Sullivan, Asli Enez Darcin, Hatice Aksu, Nesrin Dilbaz, Onur Noyan, Momoko Kitazawa, Shunya Kurokawa, Yuki Tazawa, Alejandro Anselmi, Cecilia Cracco, Ana Ines Machado, Natalia Estrade, Diego De Leo, Jackie Curtis, Michael Berk, Philip Ward, Scott Teasdale, Simon Rosenbaum, Wolfgang Marx, Adrian Vasile Horodnic, Liviu Oprea, Ovidiu Alexinschi, Petru Ifteni, Serban Turliuc, Tudor Ciuhodaru, Alexandra Bolos, Valentin Matei, Dorien H. Nieman, Iris Sommer, Jim van Os, Therese van Amelsvoort, Ching-Fang Sun, Ta-wei Guu, Can Jiao, Jieting Zhang, Jialin Fan, Liye Zou, Xin Yu, Xinli Chi, Philippe de Timary, Ruud van Winkel, Bernardo Ng, Edilberto Pena, Ramon Arellano, Raquel Roman, Thelma Sanchez, Larisa Movina, Pedro Morgado, Sofia Brissos, Oleg Aizberg, Anna Mosina, Damir Krinitski, James Mugisha, Dena Sadeghi-Bahmani, Farshad Sheybani, Masoud Sadeghi, Samira Hadi, Serge Brand, Antonia Errazuriz, Nicolas Crossley, Dragana Ignjatovic Ristic, Carlos Lopez-Jaramillo, Dimitris Efthymiou, Praveenlal Kuttichira, Roy Abraham Kallivayalil, Afzal Javed, Muhammad Iqbal Afridi, Bawo James, Omonefe Joy Seb-Akahomen, Jess Fiedorowicz, Andre F. Carvalho, Jeff Daskalakis, Lakshmi N. Yatham, Lin Yang, Tarek Okasha, Aicha Dahdouh, Bjoern Gerdle, Jari Tiihonen, Jae Il Shin, Jinhee Lee, Ahmed Mhalla, Lotfi Gaha, Takoua Brahim, Kuanysh Altynbekov, Nikolay Negay, Saltanat Nurmagambetova, Yasser Abu Jamei, Mark Weiser, Christoph U. Correll

Summary: The COH-FIT survey is a valid instrument to measure global mental health during the COVID-19 pandemic. The study confirmed the validity of COH-FIT items and the internal reliability of the co-primary outcome, the P-score. The survey has been translated into 30 languages and measures various mental health symptoms and factors.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Clinical Neurology

Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation

Sameer Jauhar, Paolo Fusar-Poli, David Foreman

Summary: The randomised controlled trial examines the effects of reducing and discontinuing antipsychotics on social functioning and continued use in schizophrenia patients. However, methodological issues mentioned in the trial protocol could potentially impact the interpretation of the findings, such as non-blinded outcome measurement, treatment as usual comparator, and possible sample size problems.

JOURNAL OF PSYCHOPHARMACOLOGY (2023)

Review Psychiatry

The Lived Experiences of Family Members and Carers of People with Psychosis: A Bottom-Up Review Co-Written by Experts by Experience and Academics

Andres Estrade, Juliana Onwumere, Jemma Venables, Lorenzo Gilardi, Ana Cabrera, Joseba Rico, Arif Hoque, Jummy Otaiku, Nicholas Hunter, Peter Keri, Lily Kpodo, Charlene Sunkel, Jianan Bao, David Shiers, Ilaria Bonoldi, Elizabeth Kuipers, Paolo Fusar-Poli

Summary: Informal caregivers of individuals with psychotic disorder have significant experiences that deserve recognition and support in the recovery process. Through a bottom-up review of first-person accounts, we identified key themes related to dealing with the disorder, navigating healthcare systems, and fighting stigma. The voices of relatives and carers provide valuable insights throughout the different stages of the disorder, and mental health professionals should actively acknowledge and support their contributions.

PSYCHOPATHOLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression

Sameer Jauhar, Danilo Arnone, David S. Baldwin, Michael Bloomfield, Michael Browning, Anthony J. Cleare, Phillip Corlett, J. F. William Deakin, David Erritzoe, Cynthia Fu, Paolo Fusar-Poli, Guy M. Goodwin, Joseph Hayes, Robert Howard, Oliver D. Howes, Mario F. Juruena, Raymond W. Lam, Stephen M. Lawrie, Hamish McAllister-Williams, Steven Marwaha, David Matuskey, Robert A. McCutcheon, David J. Nutt, Carmine Pariante, Toby Pillinger, Rajiv Radhakrishnan, James Rucker, Sudhakar Selvaraj, Paul Stokes, Rachel Upthegrove, Nefize Yalin, Lakshmi Yatham, Allan H. Young, Roland Zahn, Philip J. Cowen

Summary: A recent umbrella review found no consistent evidence linking serotonin to the pathophysiology of depression. However, we argue that this conclusion is overstated due to methodological weaknesses, selective reporting of data, oversimplification, and errors in the interpretation of neuropsychopharmacological findings. We use the examples of tryptophan depletion and serotonergic molecular imaging, the two most relevant research areas, to support our argument.

MOLECULAR PSYCHIATRY (2023)

Review Psychiatry

Characteristics and clinical correlates of risk symptoms in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis

Saskia M. Cooper, Paolo Fusar-Poli, Peter J. Uhlhaas

Summary: Emerging evidence suggests that the duration of risk symptoms may impact clinical outcomes in clinical high-risk for psychosis (CHR-P) individuals. A meta-analysis was conducted to explore this hypothesis based on studies examining the duration of risk symptoms in relation to clinical outcomes in CHR-P populations. The findings suggest that the duration of risk symptoms is not associated with transition to psychosis at 12 months, but may affect remission. However, further research is needed in this area due to the small database.

SCHIZOPHRENIA RESEARCH (2023)

Article Medicine, General & Internal

Associations of remote mental healthcare with clinical outcomes: a natural language processing enriched electronic health record data study protocol

Muhammad Shamim Ahmed, Daisy Kornblum, Dominic Oliver, Paolo Fusar-Poli, Rashmi Patel

Summary: This study aims to investigate the associations between remote mental healthcare and clinical outcomes by analyzing a large electronic health record dataset. The study will analyze clinical and demographic characteristics of patients and compare the clinical outcomes of remote versus in-person assessments. Additionally, natural language processing will be used to analyze the content differences between remote and in-person assessments.

BMJ OPEN (2023)

Article Neurosciences

The coupling between the spatial and temporal scales of neural processes revealed by a joint time-vertex connectome spectral analysis

Joan Rue-Queralt, Valentina Mancini, Vincent Rochas, Caren Latreche, Peter J. Uhlhaas, Christoph M. Michel, Gijs Plomp, Stephan Eliez, Patric Hagmann

Summary: This study investigated the brain's information processing mechanisms at different spatial scales using Joint Time-Vertex Spectral Analysis. The results demonstrated that different frequency bands correspond to different information processing mechanisms, with low frequencies associated with spatially distributed integration activity and high frequencies associated with localized electrical segregation activity.

NEUROIMAGE (2023)

Article Psychiatry

Spectral and phase-coherence correlates of impaired auditory mismatch negativity (MMN) in schizophrenia: A MEG study

Andreas Sauer, Tineke Grent-'t-Jong, Maor Zeev-Wolf, Wolf Singer, Abraham Goldstein, Peter J. Uhlhaas

Summary: This study aimed to examine the mechanisms underlying dysfunctional mismatch negativity (MMN) in schizophrenia. The researchers found that schizophrenia patients showed reduced amplitude and spectral power in various brain regions, as well as impaired phase coherence and stimulus-specific adaptation. These findings suggest that deficits in theta-/alpha- and gamma-band activity, as well as impaired spectral responses, contribute to dysfunctional MMN generation in schizophrenia.

SCHIZOPHRENIA RESEARCH (2023)

Article Psychiatry

Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis

Shalaila S. Haas, Ruiyang Ge, Ingrid Agartz, G. Paul Amminger, Ole A. Andreassen, Peter Bachman, Inmaculada Baeza, Sunah Choi, Tiziano Colibazzi, Vanessa L. Cropley, Camilo de la Fuente-Sandoval, Bjorn H. Ebdrup, Adriana Fortea, Paolo Fusar-Poli, Birte Yding Glenthoj, Louise Birkedal Glenthoj, Kristen M. Haut, Rebecca A. Hayes, Karsten Heekeren, Christine I. Hooker, Wu Jeong Hwang, Neda Jahanshad, Michael Kaess, Kiyoto Kasai, Naoyuki Katagiri, Minah Kim, Jochen Kindler, Shinsuke Koike, Tina D. Kristensen, Jun Soo Kwon, Stephen M. Lawrie, Irina Lebedeva, Jimmy Lee, Imke L. J. Lemmers-Jansen, Ashleigh Lin, Xiaoqian Ma, Daniel H. Mathalon, Philip McGuire, Chantal Michel, Romina Mizrahi, Masafumi Mizuno, Paul Moller, Ricardo Mora-Duran, Barnaby Nelson, Takahiro Nemoto, Merete Nordentoft, Dorte Nordholm, Maria A. Omelchenko, Christos Pantelis, Jose C. Pariente, Jayachandra M. Raghava, Francisco Reyes-Madrigal, Jan I. Rossberg, Wulf Roessler, Dean F. Salisbury, Daiki Sasabayashi, Ulrich Schall, Lukasz Smigielski, Gisela Sugranyes, Michio Suzuki, Tsutomu Takahashi, Christian K. Tamnes, Anastasia Theodoridou, Sophia I. Thomopoulos, Paul M. Thompson, Alexander S. Tomyshev, Peter J. Uhlhaas, Tor G. Vaernes, Therese A. M. J. van Amelsvoort, Theo G. M. van Erp, James A. Waltz, Christina Wenneberg, Lars T. Westlye, Stephen J. Wood, Juan H. Zhou, Dennis Hernaus, Maria Jalbrzikowski, Rene S. Kahn, Cheryl M. Corcoran, Sophia Frangou

Summary: This case-control study suggests that macroscale neuromorphometric measures may not be sufficient as diagnostic biomarkers for psychosis risk. The study assesses brain morphometric changes in individuals at high risk for psychosis and their association with positive symptoms, cognition, and conversion to a psychotic disorder.

JAMA PSYCHIATRY (2023)

暂无数据